Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Enbrel
Enbrel
Clover Initiates Ph I Study of Enbrel Biosimilar in China
CP Wire
Wed, 08/1/18 - 10:35 am
Clover BioPharmaceuticals
Enbrel
Amgen
biosimilars
SCB-808
China
Clover Initiates Ph I Study of Enbrel Biosimilar in China
Wed, 08/1/18 - 09:43 am
Clover BioPharmaceuticals
SCB-808
Enbrel
generics
Novartis touts effectiveness, safety of autoimmune drug copies
Yahoo/Reuters
Fri, 06/15/18 - 09:57 am
Novartis
biosimilars
JNJ
Remicade
Amgen
Enbrel
autoimmune disease
Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene: analyst
Fierce Pharma
Wed, 05/23/18 - 09:54 am
Pfizer
Xeljanz
AbbVie
Upadacitinib
JAK inhibitors
Amgen
Enbrel
Celgene
Novartis Likely Delayed In Launching Copycat Of Amgen Blockbuster
Investors Business Daily
Fri, 03/30/18 - 09:26 am
Novartis
Amgen
Enbrel
biosimilars
What to Expect From Amgen, Inc. in 2018
Motley Fool
Sun, 01/21/18 - 10:40 am
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
Will 2018 Be Amgen Inc.'s Best Year Yet?
Motley Fool
Wed, 01/17/18 - 10:08 am
Amgen
Enbrel
Aranesp
Neulasta
Epogen
Pfizer’s Declining-Revenue Products in 2Q17
Market Realist
Tue, 08/15/17 - 09:33 am
Pfizer
Prevnar
Enbrel
Zyvox
Viagra
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Novartis
rheumatoid arthritis
generics
Sandoz
Amgen
Enbrel
JNJ
Remicade
AbbVie
Humira
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Wed, 07/5/17 - 09:37 am
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Thu, 06/29/17 - 09:43 am
Novartis
biosimilars
Enbrel
Europe
Sandoz
Erelzi
Roche
Rituxan
The 19 Best-Selling Prescription Drugs of All-Time
Motley Fool
Mon, 03/13/17 - 11:29 am
Lipitor
Humira
Seretide
Remicade
Plavix
Enbrel
Rituxan
Herceptin
Avastin
Nexium
Zyprexa
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Investopedia
Thu, 02/23/17 - 09:39 pm
Amgen
Enbrel
rheumatoid arthritis
What to expect from Pfizer earnings: competition on two fronts
Marketwatch
Sat, 01/28/17 - 02:44 pm
Pfizer
earnings
Enbrel
Lipitor
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Novartis
Enbrel
patents
Erelzi
Amgen
biosimilars
rheumatoid arthritis
Enbrel Sales Were Flat in 3Q16
Market Realist
Thu, 12/29/16 - 10:14 am
Enbrel
Amgen
Why Is Enbrel So Important for Amgen?
Marketwatch
Wed, 12/28/16 - 11:50 am
Amgen
Enbrel
FDA OKs Expanded Use of Amgen's Enbrel
Investopedia
Thu, 11/10/16 - 10:18 am
FDA
Amgen
Enbrel
pediatrics
psoriasis
Biogen’s Tecfidera, Amgen’s Enbrel tell a tale of pricing power and weakness
Fierce Pharma
Mon, 10/31/16 - 09:40 am
Biogen
Tecfidera
Amgen
Enbrel
drug pricing
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »